NASDAQ
Alterity Therapeutics Limited (ATHE) has a revenue compound annual growth rate of 118.77% over 5 years and 40.86% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.